{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:05:19Z","timestamp":1792292719337,"version":"4.4.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0170661","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T13:45:45Z","timestamp":1486043145000},"page":"e0170661","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study"],"prefix":"10.1371","volume":"12","author":[{"given":"Laurent","family":"Cotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Antoine","family":"Valantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Allavena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Cabi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Poizot-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Cheret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dellamonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Parienti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Dat\u2019AIDS study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"ref1","unstructured":"European AIDS clinical society. Guidelines for the clinical management and treatment of HIV infected adults in Europe. Version 8.0, October 2015. [Internet]. [cited 31 May 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.eacsociety.org\/files\/2015_eacsguidelines_8.0-english_revised-20151104.pdf\" xlink:type=\"simple\">http:\/\/www.eacsociety.org\/files\/2015_eacsguidelines_8.0-english_revised-20151104.pdf<\/ext-link>"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"AJ Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1086\/596482","article-title":"Better adherence with once-daily antiretroviral regimens: a meta-analysis","volume":"48","author":"J-J Parienti","year":"2009","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/14656566.8.3.371","article-title":"Efavirenz\/emtricitabine\/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?","volume":"8","author":"M Goicoechea","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"ref5","first-page":"427","article-title":"The first once-daily single-tablet regimen for the treatment of HIV-infected patients","volume":"43","author":"B Killingley","year":"2007","journal-title":"Drugs Today Barc Spain 1998"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"JE Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1185\/03007995.2013.844685","article-title":"Single-tablet regimens in HIV: does it really make a difference?","volume":"30","author":"I Aldir","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-014-0024-z","article-title":"Single-Tablet Regimens in HIV Therapy","volume":"3","author":"N Astuti","year":"2014","journal-title":"Infect Dis Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-156-11-201206050-00419","article-title":"Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel","volume":"156","author":"MA Thompson","year":"2012","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1097\/QAD.0b013e328340a209","article-title":"A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people","volume":"24","author":"DR Bangsberg","year":"2010","journal-title":"AIDS Lond Engl"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1258\/ijsa.2011.011292","article-title":"Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients","volume":"23","author":"A Buscher","year":"2012","journal-title":"Int J STD AIDS"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003028","article-title":"Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV","volume":"3","author":"CJ Cohen","year":"2013","journal-title":"BMJ Open"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1310\/hct1202-71","article-title":"Factors associated with complete adherence to HIV combination antiretroviral therapy","volume":"12","author":"T Juday","year":"2011","journal-title":"HIV Clin Trials"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/PPA.S31385","article-title":"Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era","volume":"6","author":"G Sterrantino","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"ref15","first-page":"115","article-title":"One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects","volume":"4","author":"M Airoldi","year":"2010","journal-title":"Patient Prefer Adherence"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.sapharm.2010.12.004","article-title":"Does combining antiretroviral agents in a single dosage form enhance quality of life of HIV\/AIDS patients? A cost-utility study","volume":"8","author":"A Ganguli","year":"2012","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e31591","DOI":"10.1371\/journal.pone.0031591","article-title":"Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States","volume":"7","author":"PE Sax","year":"2012","journal-title":"PloS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMct1215532","article-title":"Single-pill combination regimens for treatment of HIV-1 infection","volume":"371","author":"M Gandhi","year":"2014","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-1293.2009.00719.x","article-title":"A large French prospective cohort of HIV-infected patients: the Nadis Cohort","volume":"10","author":"P Pugliese","year":"2009","journal-title":"HIV Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jir505","article-title":"Abacavir\/lamivudine versus tenofovir DF\/emtricitabine as part of combination regimens for initial treatment of HIV: final results","volume":"204","author":"PE Sax","year":"2011","journal-title":"J Infect Dis"},{"key":"ref21","first-page":"680","article-title":"Propensity score: interest and limits","volume":"94","author":"F Kwiatkowski","year":"2007","journal-title":"Bull Cancer (Paris)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/jac\/dkv083","article-title":"Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database","volume":"70","author":"F Raffi","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 4","key":"ref23","doi-asserted-by":"crossref","first-page":"18098","DOI":"10.7448\/IAS.15.6.18098","article-title":"Adherence in HIV-positive patients treated with single-tablet regimens and multi-pill regimens: findings from the COMPACT study","volume":"15","author":"A Antinori","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/cid\/ciu046","article-title":"Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials","volume":"58","author":"JB Nachega","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1677","DOI":"10.1097\/MD.0000000000001677","article-title":"Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens","volume":"94","author":"PG Clay","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/09540121.2015.1096890","article-title":"Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate versus efavirenz\/emtricitabine\/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment","volume":"28","author":"EL Wilkins","year":"2016","journal-title":"AIDS Care"},{"key":"ref27","first-page":"1213","article-title":"Efficacy, safety, and patient acceptability of elvitegravir\/cobicistat\/emtricitabine\/tenofovir in the treatment of HIV\/AIDS","volume":"9","author":"R Prinapori","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/jac\/dkt003","article-title":"Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses","volume":"68","author":"S Lambert-Niclot","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e2783","DOI":"10.1371\/journal.pone.0002783","article-title":"Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels","volume":"3","author":"J-J Parienti","year":"2008","journal-title":"PloS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1086\/383572","article-title":"Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy","volume":"38","author":"J-J Parienti","year":"2004","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"ofw109","DOI":"10.1093\/ofid\/ofw109","article-title":"Unanticipated Effects of New Drug Availability on Antiretroviral Durability: Implications for Comparative Effectiveness Research","volume":"3","author":"EF Eaton","year":"2016","journal-title":"Open Forum Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0170661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T02:58:52Z","timestamp":1719025132000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0170661"}},"subtitle":[],"editor":[{"given":"Dimitrios","family":"Paraskevis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0170661","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}